Tamir Poleg Discloses Multiple REAX Share Sales in Form 144
Rhea-AI Filing Summary
Real Brokerage Inc. (REAX) filed a Form 144 reporting a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services on 08/13/2025. The filing lists an aggregate market value of $223,650 and shows 208,121,000 shares outstanding for the issuer.
The Form states the shares were acquired on 08/13/2025 by stock option exercise from the issuer and payment was in cash. The filing also documents numerous sales by Tamir Poleg during May–August 2025 (examples include 100,000 shares on 06/03/2025 for $431,500 and 73,063 shares on 08/11/2025 for $301,311.81). The filer certifies no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider exercised options and plans to sell 50,000 shares; multiple recent insider disposals are disclosed, appearing as routine insider liquidity.
The Form 144 shows a same-day option exercise and proposed sale of 50,000 REAX shares via Morgan Stanley with an aggregate value of $223,650. The issuer's outstanding share count is provided as 208,121,000, which contextualizes the size of the notice. The filing also catalogs many prior sales by Tamir Poleg across May–August 2025, including several large blocks. From a market-movement perspective, these are standard insider disclosures that increase transparency; they do not, on their face, indicate undisclosed operational issues because the filer affirms no material nonpublic information.
TL;DR: Form 144 documents compliant disclosure of an option exercise and planned sale; repeated insider sales warrant attention for governance and signaling.
The filing includes the required certification about material information and references trading-plan considerations. It records acquisition by stock option exercise and cash payment, and names the executing broker. The extensive list of sales by an individual named Tamir Poleg over recent months is relevant for governance review and insider trading oversight, though the filing itself is a routine compliance document rather than an operational disclosure.